Word: fda
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
That was the subject of an Oct. 31 daylong meeting of the Food and Drug Administration's (FDA) Science Board. Earlier last week a panel commissioned by the Science Board released its review of the FDA's safety report, which concluded in August that current levels of BPA exposure posed no real health risk. The Science Board convened Friday to discuss the panel's findings - a highly critical 17-page review that deemed the FDA's conclusions flawed - and to hear comments from the public about whether the compound should be banned from food and beverage containers. The board will...
...renewed uproar over plastic? Since the FDA completed its original analysis in August, additional data on the potential health effects of BPA have emerged, linking high levels of BPA exposure to increased risk of heart disease and diabetes and even a decreased sensitivity to chemotherapy in cancer patients. The compound is also linked to developmental and brain effects in infants; BPA is known to mimic the hormone estrogen in the body, which can cause changes in developing fetuses and infants. "There is enough evidence today for the FDA to take the precaution and to certainly get BPA out of infant...
...FDA's initial assessment - which it has not rescinded - that "an adequate margin of safety exists for BPA at current levels of exposure from food-contact uses, for infants and adults" was based on data available at the time. Back in April, for example, the National Toxicology Program, which is part of the National Institutes of Health (NIH), released a preliminary report expressing "some concern" that according to studies done in animals, BPA could have neural and behavioral effects on fetuses, infants and children at current levels of exposure. Recent surveys by the Centers for Disease Control and Prevention...
...professors said that Congress should give the FDA the power to restrict levels of nicotine and to more forcefully regulate the chemical content of snuff in order to ensure that tobacco companies are not engineering their products to increase use among young people or boost addiction in current users...
...FDA has not yet responded to Griffiths. FDA spokesman Michael Herndon told me in an e-mail that the CSPI petition is still "active and pending." When I asked why it has taken 11 years - so far - to review it, he replied, "Some petitions may take longer depending on agency workload and complexity of the issue...